Search results
Found 16132 matches for
The US Food and Drug Administration (FDA) has recently licensed a form of ketamine – esketamine – as a treatment for depression which is resistant to other treatments. It is administered as a nasal spray in a clinic, initially twice a week, then weekly or fortnightly. Regular doses of the drug are necessary to prevent relapse.
Projects
NIHR Programme Grant- A collaborative programme of research to support the National Suicide Prevention Strategy Multicentre Study of Self-harm in England- A national collaboration to provide a basis for studies of self-harm in England Wellcome Trust Safer Storage of Pesticides Project
Research projects
• APOE • OPDC • Whitehall • UKDP • conBRIO • other (PTSD, COMT, etc)
Co-PICS
A multi site study exploring how people from diverse ethnic groups experience and cope with multiple conditions including psychosis whilst managing adverse social and environmental circumstances.
Use of personal data
Information on the use of personal service user data in the EXTEND study
Get Involved
To have entries removed, contact Reception with a link to the entry